A team of scientists from the National University of Singapore (NUS) has successfully identified the urinary biomarkers of an emerging subclass of synthetic cannabinoids, called OXIZID, to monitor potential abuse.
Inside cells, proteins constantly interact with each other to carry out different functions. For some diseases in which these functions are altered, blocking the binding between two or more proteins emerges as a possible therapeutic approach.
Science Minister George Freeman has today (30 November) awarded up to £12 million to UK regulators to help drive forward innovation, remove red tape and establish the UK as world leader in technologies of the future - from AI to help treat rare diseases, to drones monitoring safety on construction sites.
Zimbabwe's approval of the long-acting cabotegravir (CAB-LA) for use by HIV-negative people to reduce the risk of getting HIV could pave the way for effective options for HIV prevention, experts say.